Publications
5532 Results
- Journal / Conference
- ASCO 14:273(#760)
- Year
- 1995
- Research Committee(s)
- Gynecologic
- Study Number(s)
- SWOG-8501 (INT-0051)
Phase III study of intraperitoneal (IP) cisplatin (CDDP)/intravenous (IV) cyclophosphamide (CPA) vs IV CDDP/IV CPA in patients (pts) with optimal disease stage III ovarian cancer: A SWOG-GOG-ECOG Intergroup Study (INT-0051)
- Journal / Conference
- International Academy of Pathology Book of Abstracts :111A(#644)
- Year
- 1995
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-8516 (INT-0067), SWOG-8819
A Southwest Oncology Group (SWOG) analysis of the anaplastic large cell lymphoma (ALCL) entities in the revised European American lymphoma (REAL) classification.
- Journal / Conference
- International Academy of Pathology Book of Abstracts :51A(#284)
- Year
- 1995
- Research Committee(s)
- Melanoma
- Study Number(s)
- SWOG-8049
Tumor infiltrating lymphocytes (TILs) instage I cutaneous melanoma: A Southwest Oncology Group study.
- Journal / Conference
- ASCO 14:202(#486)
- Year
- 1995
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-9060
Evaluation of multimodality treatment of locoregional esophageal carcinoma: SWOG 9060.
- Journal / Conference
- ASCO 14:270(#750)
- Year
- 1995
- Research Committee(s)
- Gynecologic
- Study Number(s)
- SWOG-8835
Elevated serum CA-125: An adverse prognostic factor for survival in epithelial ovarian cancer (EOC) with minimal residual disease after second-look laparotomy (SLL)
- Journal / Conference
- ASCO 14:410(#1298)
- Year
- 1995
- Research Committee(s)
- Melanoma
- Study Number(s)
- SWOG-8107, SWOG-8118, SWOG-8324, SWOG-8723, SWOG-8754, SWOG-8804, SWOG-8921
Survival and response to treatment in patients (pts) with metastatic melanoma from intraocular primaries (MMIP) on SWOG studies.
- Journal / Conference
- ASCO 14:418(#1330)
- Year
- 1995
- Research Committee(s)
- Melanoma
- Study Number(s)
- SWOG-9116
Phase II trial of piroxantrone in disseminated malignant melanoma: A Southwest Oncology Group study.
- Journal / Conference
- ASCO 14:388(#1209)
- Year
- 1995
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-8942
Autologous bone marrow transplantation (ABMT) for patients with diffuse non-Hodgkin's lymphoma: Value of augmented preparative regimens. A Southwest Oncology Group (SWOG) trial.
- Journal / Conference
- ASCO 14:235(#613)
- Year
- 1995
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8894 (INT-0105) (EST-2889)
The prognostic significance of prostate specific antigen (PSA) in stage D2 prostate cancer (PC) interim evaluation of Intergroup study 0105
- Journal / Conference
- ASCO 14:146(#281)
- Year
- 1995
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-9401 (NCCTG-90-46-52)